Subbu Nambi
Stock Analyst at Guggenheim
(4.92)
# 199
Out of 4,966 analysts
182
Total ratings
74%
Success rate
37.4%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FRNM Freenome | Initiated Coverage: Buy | $21 | $14.37 | +46.14% | 1 | Aug 20, 2026 | |
| NTRA Natera | Reiterated: Buy | $290 → $360 | $328.93 | +9.45% | 8 | Aug 11, 2026 | |
| CYRX Cryoport | Reiterated: Buy | $12 → $16 | $15.57 | +2.76% | 5 | Aug 6, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $75 | $76.23 | -1.61% | 12 | Aug 5, 2026 | |
| BRKR Bruker | Reiterated: Buy | $70 | $53.43 | +31.01% | 10 | Aug 4, 2026 | |
| WAT Waters | Reiterated: Buy | $440 | $408.34 | +7.75% | 6 | Aug 4, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $65 | $59.01 | +10.15% | 11 | Aug 3, 2026 | |
| GH Guardant Health | Reiterated: Buy | $190 | $157.38 | +20.73% | 17 | Jul 31, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $65 | $41.56 | +56.40% | 11 | Jul 31, 2026 | |
| ILMN Illumina | Reiterated: Buy | $200 → $226 | $206.45 | +9.47% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $11.76 | +2.04% | 8 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $25 | $24.20 | +3.31% | 5 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.02 | +292.16% | 9 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $235 → $200 | $200.15 | -0.07% | 8 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $125 | $98.77 | +26.56% | 6 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $107 | $126.98 | -15.73% | 9 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $74 | $85.27 | -13.21% | 8 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.53 | - | 3 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $31.91 | +47.29% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $16.21 | -19.80% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $7.87 | -11.05% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $165.18 | - | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.30 | - | 1 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.32 | - | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $124.31 | - | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €263.00 | €232.90 | +12.92% | 2 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $24.34 | n/a | 1 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.42 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $68.59 | n/a | 2 | Feb 23, 2025 |
Freenome
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $14.37
Upside: +46.14%
Natera
Aug 11, 2026
Reiterated: Buy
Price Target: $290 → $360
Current: $328.93
Upside: +9.45%
Cryoport
Aug 6, 2026
Reiterated: Buy
Price Target: $12 → $16
Current: $15.57
Upside: +2.76%
GRAIL
Aug 5, 2026
Reiterated: Buy
Price Target: $75
Current: $76.23
Upside: -1.61%
Bruker
Aug 4, 2026
Reiterated: Buy
Price Target: $70
Current: $53.43
Upside: +31.01%
Waters
Aug 4, 2026
Reiterated: Buy
Price Target: $440
Current: $408.34
Upside: +7.75%
Tempus AI
Aug 3, 2026
Reiterated: Buy
Price Target: $65
Current: $59.01
Upside: +10.15%
Guardant Health
Jul 31, 2026
Reiterated: Buy
Price Target: $190
Current: $157.38
Upside: +20.73%
Veracyte
Jul 31, 2026
Reiterated: Buy
Price Target: $65
Current: $41.56
Upside: +56.40%
Illumina
Jul 30, 2026
Reiterated: Buy
Price Target: $200 → $226
Current: $206.45
Upside: +9.47%
Jul 30, 2026
Reiterated: Buy
Price Target: $12
Current: $11.76
Upside: +2.04%
Jul 29, 2026
Reiterated: Buy
Price Target: $22 → $25
Current: $24.20
Upside: +3.31%
Jul 28, 2026
Reiterated: Buy
Price Target: $4
Current: $1.02
Upside: +292.16%
Jul 21, 2026
Reiterated: Buy
Price Target: $235 → $200
Current: $200.15
Upside: -0.07%
Jun 29, 2026
Reiterated: Buy
Price Target: $120 → $125
Current: $98.77
Upside: +26.56%
Jun 29, 2026
Reiterated: Buy
Price Target: $60 → $107
Current: $126.98
Upside: -15.73%
Jun 29, 2026
Reiterated: Buy
Price Target: $70 → $74
Current: $85.27
Upside: -13.21%
May 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.53
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $47
Current: $31.91
Upside: +47.29%
May 7, 2026
Reiterated: Buy
Price Target: $13
Current: $16.21
Upside: -19.80%
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $7.87
Upside: -11.05%
Feb 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $165.18
Upside: -
Feb 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.30
Upside: -
Oct 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $17.32
Upside: -
Oct 27, 2025
Reiterated: Hold
Price Target: n/a
Current: $124.31
Upside: -
Oct 16, 2025
Reiterated: Buy
Price Target: €263.00
Current: €232.90
Upside: +12.92%
Jul 13, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $24.34
Upside: n/a
Apr 8, 2025
Downgraded: Hold
Price Target: n/a
Current: $3.42
Upside: n/a
Feb 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $68.59
Upside: n/a